Randomized Study of Adjuvant Radiotherapy After Curative Resection of HCC With Narrow Margin (RAISE)

This trial is studying whether radiation therapy after surgery reduces the chances of liver cancer (HCC) coming back in patients whose tumors were removed with very thin (narrow) surgical margins. **You may be eligible if...** - You were diagnosed with liver cancer (HCC) and had surgery to remove it completely (confirmed by imaging) - The narrowest surgical margin was 1 cm or less - You are aged 18–75 years - Your liver function is reasonably preserved (Child-Pugh score 5–7) - Your blood counts and organ function are within acceptable ranges - Your life expectancy is at least 6 months **You may NOT be eligible if...** - There are signs of remaining cancer after surgery - Your liver function is severely impaired - You have received other cancer treatments before or after surgery for this cancer - Your blood counts or organ function fall below the required levels Talk to your doctor to see if this trial is right for you.